APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rare Genetic Disease Diagnosis Solution

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rare Genetic Disease Diagnosis Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174226420311 April 2026195 pages

Choose your research edition.

Industry ResearchRare Genetic Disease Diagnosis Solution Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Rare Genetic Disease Diagnosis Solution Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Rare Genetic Disease Diagnosis Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rare Genetic Disease Diagnosis Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Rare Genetic Disease Diagnosis Solution Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Rare Genetic Disease Diagnosis Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Rare Genetic Disease Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rare Genetic Disease Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rare Genetic Disease Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rare Genetic Disease Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rare Genetic Disease Diagnosis Solution include Retrophin, 3billion, 23andMe, Ancestry, GeneDx, Ambry Genetics, QIAGEN, Illumina and PerkinElmer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Rare Genetic Disease Diagnosis Solution market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rare Genetic Disease Diagnosis Solution and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rare Genetic Disease Diagnosis Solution revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Rare Genetic Disease Diagnosis Solution market size, projected growth trends, production technologies, key applications, and end-use industries.

Rare Genetic Disease Diagnosis Solution Segment by Company

Retrophin

3billion

23andMe

Ancestry

GeneDx

Ambry Genetics

QIAGEN

Illumina

PerkinElmer

Strand Life Sciences

Rare Genetic Disease Diagnosis Solution Segment by Type

Genetic Testing

Biochemical Testing

Imaging and Diagnostic Procedures

Others

Rare Genetic Disease Diagnosis Solution Segment by Application

Clinical Genetics and Pediatric Clinic

Newborn Screening Program

Research and Development

Others

Rare Genetic Disease Diagnosis Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rare Genetic Disease Diagnosis Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rare Genetic Disease Diagnosis Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rare Genetic Disease Diagnosis Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Rare Genetic Disease Diagnosis Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rare Genetic Disease Diagnosis Solution industry.

Chapter 3: Detailed analysis of Rare Genetic Disease Diagnosis Solution companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rare Genetic Disease Diagnosis Solutionrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Genetic Testing Table 3. Key Players of Biochemical Testing Table 4. Key Players of Imaging and Diagnostic Procedures Table 3. Key Players of Others Table 4. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinical Genetics and Pediatric Clinic Table 6. Key Players of Newborn Screening Program Table 7. Key Players of Research and Development Table 8. Key Players of Others Table 9. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Rare Genetic Disease Diagnosis Solution Market Share by Region (2021-2026) Table 12. Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Rare Genetic Disease Diagnosis Solution Market Share by Region (2027-2032) Table 14. Rare Genetic Disease Diagnosis Solution Industry Trends Table 15. Rare Genetic Disease Diagnosis Solution Industry Drivers Table 16. Rare Genetic Disease Diagnosis Solution Industry Opportunities and Challenges Table 17. Rare Genetic Disease Diagnosis Solution Industry Restraints Table 18. Global Rare Genetic Disease Diagnosis Solution Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Company (2021-2026) Table 20. Global Rare Genetic Disease Diagnosis Solution Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Rare Genetic Disease Diagnosis Solution Key Company Head Office and Area Served Table 22. Global Rare Genetic Disease Diagnosis Solution Company, Product Type & Application Table 23. Global Rare Genetic Disease Diagnosis Solution Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Rare Genetic Disease Diagnosis Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Rare Genetic Disease Diagnosis Solution Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Type (2021-2026) Table 30. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Type (2027-2032) Table 31. Global Rare Genetic Disease Diagnosis Solution Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2021-2026) Table 35. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2027-2032) Table 36. Retrophin Company Information Table 37. Retrophin Business Overview Table 38. Retrophin Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Retrophin Rare Genetic Disease Diagnosis Solution Product Portfolio Table 40. Retrophin Recent Development Table 41. 3billion Company Information Table 42. 3billion Business Overview Table 43. 3billion Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. 3billion Rare Genetic Disease Diagnosis Solution Product Portfolio Table 45. 3billion Recent Development Table 46. 23andMe Company Information Table 47. 23andMe Business Overview Table 48. 23andMe Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. 23andMe Rare Genetic Disease Diagnosis Solution Product Portfolio Table 50. 23andMe Recent Development Table 51. Ancestry Company Information Table 52. Ancestry Business Overview Table 53. Ancestry Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Ancestry Rare Genetic Disease Diagnosis Solution Product Portfolio Table 55. Ancestry Recent Development Table 56. GeneDx Company Information Table 57. GeneDx Business Overview Table 58. GeneDx Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. GeneDx Rare Genetic Disease Diagnosis Solution Product Portfolio Table 60. GeneDx Recent Development Table 61. Ambry Genetics Company Information Table 62. Ambry Genetics Business Overview Table 63. Ambry Genetics Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Ambry Genetics Rare Genetic Disease Diagnosis Solution Product Portfolio Table 65. Ambry Genetics Recent Development Table 66. QIAGEN Company Information Table 67. QIAGEN Business Overview Table 68. QIAGEN Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. QIAGEN Rare Genetic Disease Diagnosis Solution Product Portfolio Table 70. QIAGEN Recent Development Table 71. Illumina Company Information Table 72. Illumina Business Overview Table 73. Illumina Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Illumina Rare Genetic Disease Diagnosis Solution Product Portfolio Table 75. Illumina Recent Development Table 76. PerkinElmer Company Information Table 77. PerkinElmer Business Overview Table 78. PerkinElmer Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. PerkinElmer Rare Genetic Disease Diagnosis Solution Product Portfolio Table 80. PerkinElmer Recent Development Table 81. Strand Life Sciences Company Information Table 82. Strand Life Sciences Business Overview Table 83. Strand Life Sciences Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Strand Life Sciences Rare Genetic Disease Diagnosis Solution Product Portfolio Table 85. Strand Life Sciences Recent Development Table 86. North America Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026) & (US$ Million) Table 87. North America Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032) & (US$ Million) Table 88. North America Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026) & (US$ Million) Table 89. North America Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032) & (US$ Million) Table 90. North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026) Table 92. North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2027-2032) Table 93. Europe Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026) Table 99. Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2027-2032) Table 100. China Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026) & (US$ Million) Table 101. China Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032) & (US$ Million) Table 102. China Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026) & (US$ Million) Table 103. China Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Rare Genetic Disease Diagnosis Solution Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026) Table 110. Asia Rare Genetic Disease Diagnosis Solution Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Rare Genetic Disease Diagnosis Solution Product Image Figure 2. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Rare Genetic Disease Diagnosis Solution Market Share by Type: 2025 VS 2032 Figure 4. Genetic Testing Image Figure 5. Biochemical Testing Image Figure 6. Imaging and Diagnostic Procedures Image Figure 7. Others Image Figure 8. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Rare Genetic Disease Diagnosis Solution Market Share by Application: 2025 VS 2032 Figure 10. Clinical Genetics and Pediatric Clinic Image Figure 11. Newborn Screening Program Image Figure 12. Research and Development Image Figure 13. Others Image Figure 14. Global Rare Genetic Disease Diagnosis Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 16. Global Rare Genetic Disease Diagnosis Solution Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Rare Genetic Disease Diagnosis Solution Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Rare Genetic Disease Diagnosis Solution Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Rare Genetic Disease Diagnosis Solution Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Type (2021-2032) Figure 23. Global Rare Genetic Disease Diagnosis Solution Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2021-2032) Figure 25. North America Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 26. North America Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032) Figure 27. North America Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032) Figure 28. North America Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032) Figure 29. United States Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 30. Canada Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 32. Europe Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 33. Europe Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032) Figure 34. Europe Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032) Figure 35. Europe Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032) Figure 36. Germany Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 37. France Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 39. Italy Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 40. Russia Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 42. China Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 43. China Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032) Figure 44. China Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032) Figure 45. Asia Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 46. Asia Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032) Figure 47. Asia Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032) Figure 48. Asia Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032) Figure 49. Japan Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 53. India Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 54. Australia Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032) Figure 59. Brazil Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 64. UAE Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 66. Chile Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Genetic Testing
  • Biochemical Testing
  • Imaging and Diagnostic Procedures
  • Others
Applications
  • Clinical Genetics and Pediatric Clinic
  • Newborn Screening Program
  • Research and Development
  • Others
Companies covered
  • Retrophin
  • 3billion
  • 23andMe
  • Ancestry
  • GeneDx
  • Ambry Genetics
  • QIAGEN
  • Illumina
  • PerkinElmer
  • Strand Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Genetic Testing
  5. 1.2.3 Biochemical Testing
  6. 1.2.4 Imaging and Diagnostic Procedures
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Clinical Genetics and Pediatric Clinic
  11. 1.3.3 Newborn Screening Program
  12. 1.3.4 Research and Development
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Rare Genetic Disease Diagnosis Solution Growth Trends by Region
  16. 1.5.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Rare Genetic Disease Diagnosis Solution Market Size by Region (2021-2026)
  18. 1.5.3 Rare Genetic Disease Diagnosis Solution Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Rare Genetic Disease Diagnosis Solution Market Dynamics
  1. 2.1 Rare Genetic Disease Diagnosis Solution Industry Trends
  2. 2.2 Rare Genetic Disease Diagnosis Solution Industry Drivers
  3. 2.3 Rare Genetic Disease Diagnosis Solution Industry Opportunities and Challenges
  4. 2.4 Rare Genetic Disease Diagnosis Solution Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Rare Genetic Disease Diagnosis Solution Revenue by Company (2021-2026)
  2. 3.2 Global Rare Genetic Disease Diagnosis Solution Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Rare Genetic Disease Diagnosis Solution Key Company Head office and Area Served
  4. 3.4 Global Rare Genetic Disease Diagnosis Solution Company, Product Type & Application
  5. 3.5 Global Rare Genetic Disease Diagnosis Solution Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Rare Genetic Disease Diagnosis Solution Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Rare Genetic Disease Diagnosis Solution Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Rare Genetic Disease Diagnosis Solution Tier 1, Tier 2, and Tier 3
4 Rare Genetic Disease Diagnosis Solution Market by Type
  1. 4.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2032)
  3. 4.3 Global Rare Genetic Disease Diagnosis Solution Market Size Share by Type (2021-2032)
5 Rare Genetic Disease Diagnosis Solution Market by Application
  1. 5.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2032)
  3. 5.3 Global Rare Genetic Disease Diagnosis Solution Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Retrophin
  2. 6.1.1 Retrophin Company Information
  3. 6.1.2 Retrophin Business Overview
  4. 6.1.3 Retrophin Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Retrophin Rare Genetic Disease Diagnosis Solution Product Portfolio
  6. 6.1.5 Retrophin Recent Developments
  7. 6.2 3billion
  8. 6.2.1 3billion Company Information
  9. 6.2.2 3billion Business Overview
  10. 6.2.3 3billion Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 3billion Rare Genetic Disease Diagnosis Solution Product Portfolio
  12. 6.2.5 3billion Recent Developments
  13. 6.3 23andMe
  14. 6.3.1 23andMe Company Information
  15. 6.3.2 23andMe Business Overview
  16. 6.3.3 23andMe Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 23andMe Rare Genetic Disease Diagnosis Solution Product Portfolio
  18. 6.3.5 23andMe Recent Developments
  19. 6.4 Ancestry
  20. 6.4.1 Ancestry Company Information
  21. 6.4.2 Ancestry Business Overview
  22. 6.4.3 Ancestry Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Ancestry Rare Genetic Disease Diagnosis Solution Product Portfolio
  24. 6.4.5 Ancestry Recent Developments
  25. 6.5 GeneDx
  26. 6.5.1 GeneDx Company Information
  27. 6.5.2 GeneDx Business Overview
  28. 6.5.3 GeneDx Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GeneDx Rare Genetic Disease Diagnosis Solution Product Portfolio
  30. 6.5.5 GeneDx Recent Developments
  31. 6.6 Ambry Genetics
  32. 6.6.1 Ambry Genetics Company Information
  33. 6.6.2 Ambry Genetics Business Overview
  34. 6.6.3 Ambry Genetics Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Ambry Genetics Rare Genetic Disease Diagnosis Solution Product Portfolio
  36. 6.6.5 Ambry Genetics Recent Developments
  37. 6.7 QIAGEN
  38. 6.7.1 QIAGEN Company Information
  39. 6.7.2 QIAGEN Business Overview
  40. 6.7.3 QIAGEN Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 QIAGEN Rare Genetic Disease Diagnosis Solution Product Portfolio
  42. 6.7.5 QIAGEN Recent Developments
  43. 6.8 Illumina
  44. 6.8.1 Illumina Company Information
  45. 6.8.2 Illumina Business Overview
  46. 6.8.3 Illumina Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Illumina Rare Genetic Disease Diagnosis Solution Product Portfolio
  48. 6.8.5 Illumina Recent Developments
  49. 6.9 PerkinElmer
  50. 6.9.1 PerkinElmer Company Information
  51. 6.9.2 PerkinElmer Business Overview
  52. 6.9.3 PerkinElmer Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 PerkinElmer Rare Genetic Disease Diagnosis Solution Product Portfolio
  54. 6.9.5 PerkinElmer Recent Developments
  55. 6.10 Strand Life Sciences
  56. 6.10.1 Strand Life Sciences Company Information
  57. 6.10.2 Strand Life Sciences Business Overview
  58. 6.10.3 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Product Portfolio
  60. 6.10.5 Strand Life Sciences Recent Developments
7 North America
  1. 7.1 North America Rare Genetic Disease Diagnosis Solution Market Size (2021-2032)
  2. 7.2 North America Rare Genetic Disease Diagnosis Solution Market Size by Type
  3. 7.2.1 North America Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026)
  4. 7.2.2 North America Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032)
  5. 7.2.3 North America Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032)
  6. 7.3 North America Rare Genetic Disease Diagnosis Solution Market Size by Application
  7. 7.3.1 North America Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026)
  8. 7.3.2 North America Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032)
  9. 7.3.3 North America Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032)
  10. 7.4 North America Rare Genetic Disease Diagnosis Solution Market Size by Country
  11. 7.4.1 North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026)
  13. 7.4.3 North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2027-2032)
  14. 7.4.4 North America Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Rare Genetic Disease Diagnosis Solution Market Size (2021-2032)
  2. 8.2 Europe Rare Genetic Disease Diagnosis Solution Market Size by Type
  3. 8.2.1 Europe Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026)
  4. 8.2.2 Europe Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032)
  5. 8.2.3 Europe Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032)
  6. 8.3 Europe Rare Genetic Disease Diagnosis Solution Market Size by Application
  7. 8.3.1 Europe Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026)
  8. 8.3.2 Europe Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032)
  9. 8.3.3 Europe Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032)
  10. 8.4 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country
  11. 8.4.1 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026)
  13. 8.4.3 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2027-2032)
  14. 8.4.4 Europe Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Rare Genetic Disease Diagnosis Solution Market Size (2021-2032)
  2. 9.2 China Rare Genetic Disease Diagnosis Solution Market Size by Type
  3. 9.2.1 China Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026)
  4. 9.2.2 China Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032)
  5. 9.2.3 China Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032)
  6. 9.3 China Rare Genetic Disease Diagnosis Solution Market Size by Application
  7. 9.3.1 China Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026)
  8. 9.3.2 China Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032)
  9. 9.3.3 China Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Rare Genetic Disease Diagnosis Solution Market Size (2021-2032)
  2. 10.2 Asia Rare Genetic Disease Diagnosis Solution Market Size by Type
  3. 10.2.1 Asia Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026)
  4. 10.2.2 Asia Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032)
  5. 10.2.3 Asia Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032)
  6. 10.3 Asia Rare Genetic Disease Diagnosis Solution Market Size by Application
  7. 10.3.1 Asia Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026)
  8. 10.3.2 Asia Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032)
  9. 10.3.3 Asia Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032)
  10. 10.4 Asia Rare Genetic Disease Diagnosis Solution Market Size by Country
  11. 10.4.1 Asia Rare Genetic Disease Diagnosis Solution Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026)
  13. 10.4.3 Asia Rare Genetic Disease Diagnosis Solution Market Size by Country (2027-2032)
  14. 10.4.4 Asia Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst